Lumexa Imaging Holdings, INC. (LMRI) — SEC Filings
Latest SEC filings for Lumexa Imaging Holdings, INC.. Recent 8-K filing on Apr 9, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Lumexa Imaging Holdings, INC. on SEC EDGAR
Overview
Lumexa Imaging Holdings, INC. (LMRI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 9, 2026: Lumexa Imaging Holdings, Inc. filed an 8-K on April 9, 2026, to disclose information under Regulation FD. The filing includes standard 8-K documents and XBRL data, with no specific financial figures or material events detailed in the provided text.
Sentiment Summary
Across 6 filings, the sentiment breakdown is: 1 bullish, 3 neutral, 2 mixed. The dominant filing sentiment for Lumexa Imaging Holdings, INC. is neutral.
Filing Type Overview
Lumexa Imaging Holdings, INC. (LMRI) has filed 4 8-K, 1 S-1/A, 1 S-1 with the SEC between Nov 2025 to Apr 2026.
Filings by Year
Recent Filings (6)
-
Lumexa Imaging Holdings Files 8-K
— 8-K · Apr 9, 2026 Risk: low
Lumexa Imaging Holdings, Inc. filed an 8-K on April 9, 2026, to disclose information under Regulation FD. The filing includes standard 8-K documents and XBRL da -
Lumexa Imaging Files 8-K on Financial Results, Reg FD Disclosure
— 8-K · Mar 26, 2026
Lumexa Imaging Holdings, Inc. filed an 8-K on March 26, 2026, reporting its results of operations and financial condition under Item 2.02 and making a Regulatio - 8-K Filing — 8-K · Dec 18, 2025
-
Lumexa Imaging Holdings Files 8-K with Key Corporate Updates
— 8-K · Dec 12, 2025 Risk: medium
Lumexa Imaging Holdings, Inc. filed an 8-K on December 12, 2025, reporting several key events. These include entering into a material definitive agreement, chan -
Lumexa Imaging Targets Nasdaq Debut with 25M Share IPO
— S-1/A · Dec 2, 2025 Risk: medium
Lumexa Imaging Holdings, Inc. (LMRI) is launching its initial public offering of 25,000,000 shares of common stock, with an anticipated price range of $17.00 to -
Lumexa Imaging Files S-1 for IPO, Targets Nasdaq Listing
— S-1 · Nov 17, 2025 Risk: medium
Lumexa Imaging Holdings, Inc. (LMRI) is launching its initial public offering, aiming to list on the Nasdaq Global Market. The company, established in 2018 as U
Risk Profile
Risk Assessment: Of LMRI's 4 recent filings, 0 were flagged as high-risk, 3 as medium-risk, and 1 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Key Executives
- Caitlin Zulla
Industry Context
The outpatient imaging center market is characterized by significant consolidation and a growing demand for advanced diagnostic services like MRI and CT. Lumexa Imaging operates as the second-largest player in the U.S., leveraging a strategy of both acquisitions and de novo growth. Key industry trends include the shift of services from hospitals to outpatient settings, technological advancements in imaging, and increasing scrutiny over reimbursement rates from payers.
Top Tags
regulation-fd (2) · IPO (2) · Diagnostic Imaging (2) · Healthcare Services (2) · Growth Strategy (2) · filing (1) · earnings (1) · financial-condition (1) · corporate-filing (1) · corporate-governance (1)
Key Numbers
- Fiscal Year End: 1231 — Indicates the end of the company's financial reporting year.
- Common Stock Offered: 25,000,000 Shares — Number of shares Lumexa Imaging Holdings, Inc. is selling in its initial public offering.
- Anticipated IPO Price Range: $17.00-$20.00 — Expected price per share for Lumexa Imaging Holdings, Inc.'s common stock.
- Outpatient Imaging Center Footprint: 184 centers — Total number of centers operated by Lumexa Imaging and its affiliates as of September 30, 2025.
- Geographic Reach: 13 states — Number of states where Lumexa Imaging operates its centers as of September 30, 2025.
- Consolidated Revenue from MRI/CT: 52% — Percentage of consolidated revenue derived from MRI and CT referrals for the nine months ended September 30, 2025.
- System-Wide Revenue from MRI/CT: 63% — Percentage of system-wide revenue derived from MRI and CT referrals for the nine months ended September 30, 2025.
- Beneficial Ownership Post-IPO: 31% — Approximate percentage of outstanding common stock beneficially owned by executive officers, directors, and WCAS after the offering.
- Acquisitions Since 2018: 20 acquisitions — Number of acquisitions made by Lumexa Imaging since its establishment in 2018.
- New Centers Opened Since 2018: 41 de novo centers — Number of new centers opened by Lumexa Imaging since its establishment in 2018.
- Patient Net Promoter Score (NPS): 91 — Lumexa Imaging's patient NPS as of September 30, 2025, based on approximately 1.2 million survey responses.
- outpatient imaging centers: 184 — Operated by Lumexa Imaging and its affiliates as of September 30, 2025, making it the second largest footprint in the U.S.
- states: 13 — Geographic reach of Lumexa Imaging's operations as of September 30, 2025
- acquisitions: 20 — Number of acquisitions made by Lumexa Imaging since 2018 to expand its footprint
- de novo centers: 41 — Number of new centers opened by Lumexa Imaging since 2018
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Lumexa Imaging Holdings, INC. (LMRI)?
Lumexa Imaging Holdings, INC. has 6 recent SEC filings from Nov 2025 to Apr 2026, including 4 8-K, 1 S-1/A, 1 S-1. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LMRI filings?
Across 6 filings, the sentiment breakdown is: 1 bullish, 3 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Lumexa Imaging Holdings, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Lumexa Imaging Holdings, INC. (LMRI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Lumexa Imaging Holdings, INC.?
Financial highlights for Lumexa Imaging Holdings, INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for LMRI?
The investment thesis for LMRI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Lumexa Imaging Holdings, INC.?
Key executives identified across Lumexa Imaging Holdings, INC.'s filings include Caitlin Zulla.
What are the main risk factors for Lumexa Imaging Holdings, INC. stock?
Of LMRI's 4 assessed filings, 0 were flagged high-risk, 3 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Lumexa Imaging Holdings, INC.?
Forward guidance and predictions for Lumexa Imaging Holdings, INC. are extracted from SEC filings as they are enriched.